Amg National Trust Bank Vertex Pharmaceuticals Inc Transaction History

Amg National Trust Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	BUY	$314.42 - $351.91 $1,886 - $2,111	6 Added 0.2%	3,049 $1.07 Million
Q1 2023 May 10, 2023	BUY	$283.23 - $323.1 $28,039 - $31,986	99 Added 3.36%	3,043 $958,000
Q4 2022 Feb 07, 2023	BUY	$285.76 - $321.48 $14,002 - $15,752	49 Added 1.69%	2,944 $850,000
Q3 2022 Nov 03, 2022	SELL	$273.83 - $305.53 $821 - $916	-3 Reduced 0.1%	2,895 $839,000
Q2 2022 Aug 05, 2022	BUY	$234.96 - $292.55 $5,639 - $7,021	24 Added 0.84%	2,898 $816,000
Q1 2022 May 10, 2022	SELL	$221.42 - $260.97 $52,919 - $62,371	-239 Reduced 7.68%	2,874 $750,000
Q4 2021 Feb 04, 2022	SELL	$177.01 - $223.45 $7,257 - $9,161	-41 Reduced 1.3%	3,113 $684,000
Q3 2021 Oct 28, 2021	BUY	$181.39 - $202.99 $572,104 - $640,230	3,154 New	3,154 $572,000

1,707

226M

1.2M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Amg National Trust Bank, based on Form 13F filings with the SEC.

Stay updated on Amg National Trust Bank with notifications on news.